Mandate

Vinge has advised Carrier in connection with the sale of its remaining stake in Beijer Ref

December 08, 2020 Capital Markets and Public M&A

Carrier Global Corporation (“Carrier”) is a leading global provider of heating, ventilating and air conditioning (HVAC), refrigeration, fire, security and building automation technologies, and is listed on the New York Stock Exchange. Beijer Ref AB (publ) (“Beijer Ref”) provides commercial and industrial refrigeration as well as heating and air conditioning products and is listed on Nasdaq Stockholm.

Carrier announced on 7 December 2020 that the company had signed a definitive agreement to sell its remaining interest in Beijer Ref to a fund managed by EQT. Under the terms of the agreement with EQT, Carrier’s remaining interest will be sold for a total value of approximately USD 1.1 billion (SEK 9.2 billion). The transaction is expected to close by the end of December 2020, subject to the receipt of a required regulatory approval. The sale follows an accelerated equity offering that occurred in September 2020 through which Carrier sold 9.25 million B shares of Beijer Ref and received proceeds of approximately USD 300 million.  

Vinge’s team consisted of Charlotte Levin, Linnéa Sellström and Anders Sundin Lundberg.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025